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Abstract. The article deals with correlation links of 
developmental mechanisms and progressing of gastroe-
sophageal reflux disease in patients with chronic forms of 
ischemic heart disease. The problem of treatment under 
conditions of comorbidity of these diseases is described.  
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Success of modern diagnostics and pharmaco-
therapy are progressing as never before, but the 
problem of comorbid diseases still remains urgent. It 
refers to one of the most complicated parts of ther-
apy. Availability of several diseases with chronic 
course provokes difficulties in making diagnosis, 
elaboration of therapeutic tactics and considerably 
worsens overall health [16, 17]. Today investigation 
of socially important diseases is rather topical in-
cluding ischemic heart disease (IHD) and gastroe-
sophageal reflux disease (GERD). Rapid increase of 
life style, negative influence of environmental fac-
tors contribute to general manifestation of morbidity 
for GERD among Ukrainian population. The topical-
ity of the problem of gastroesophageal reflux in-
creases in case of atypical manifestation of the dis-
ease and its complications which diminish the qual-
ity and provoke untimely diagnostics, and compli-
cate the selection of an adequate therapeutic tactics 
respectively [1, 2]. In addition, the cases of comorbid 
course of GERD and hypothyroidism become more 
frequent.  
In case of thyroid hormones deficiency, essen-
tial for normal functioning of practically every cell, 
pathologic changes develop in all the organs and 
systems including the digestive one [15, 24]. Hepa-
tomegaly, dyskinesia of the bile ducts and colon, 
flatulence and inclination to constipation, poor appe-
tite and atrophic gastritis [3, 10]. All these factors 
together with hypodynamia (lack of motion) and 
gaining body weight creates favourable precondi-
tions for the development of GERD and ischemic 
heart disease. As a result, it leads to comorbidity of 
these diseases [18, 27].  
Literary analysis does not provoke any doubt in 
that increased production of NO, its metabolites and 
melatonin accelerates the development and progress-
ing clinical manifestation of GERD. NO promotes 
activation of guanylate cyclase which in its turn 
leads to increased content of cGMP of the muscular 
fibers, reducing the level of intracellular calcium and 
thus promotes relaxation of the posterior esophageal 
sphincter (PES) being a central mechanism in the 
development of GERD. On the contrary, melatonin 
inhibits cGMP action and possesses a stimulating 
effect on the tonus of PES limiting a negative influ-
ence of GERD on the course of IHD [13, 14, 19]. 
Besides, melatonin has a property to regulate the 
activity of NO-synthase and neutralize free radicals 
appearing in the process of synthesis and metabolism 
of nitrogen oxide [9, 11, 12]. 
Certain evidence is found in the studies of the 
scientists performed at T.M. Mala Institute of Ther-
apy, the Academy of Medical Science of Ukraine in 
Kharkiv. They consider that the level of stable NO 
metabolites increases as far as erosive processes in 
the esophageal mucus are removed. This tendency is 
found more obvious in patients with comorbid condi-
tions. The concentration of melatonin metabolites 
depends also on the pronounced lesion of the mucous 
membrane of the esophagus. The more pronounced 
the lesion is, the lower is melatonin concentration.  
Oxidative-antioxidative imbalance being a link 
of pathogenesis of many internal diseases plays an 
important role in the development of pathogenetic 
changes [20, 23, 26, 29]. Although, today the state of 
the systems of lipid peroxide oxidation (LPO), pro-
tein oxidative modification (POM) and antioxidant 
defense (AOD) in patients with gastroesophageal 
reflux disease (GERD) and chronic forms of 
ischemic heart disease (IHD) remain insufficiently 
studied [21, 22, 25, 28]. Increased concentrations of 
oxygen active forms (OAF) and their metabolites are 
known to cause POM resulting in changes of the 
structural-functional properties of cells. Increased 
LPO intensity is found simultaneously. The influ-
ence of a destructive action of OAF in the tissues 
depends on the possibilities of the body concerning 
AOD mobilization. AOD disorders under the influ-
ence of toxic action of free radical products leads to 
structural and metabolic disorders in cells with fur-
ther necrosis. Being aware of the fact, that increased 
concentration of OAF and intensification of LPO and 
POM processes reduce regeneration properties of the 
mucous membrane in case of erosive-ulcerous lesion 
of the digestive tract, one should modify GERD ther-
apy by means of administration of antioxidant agents 
in the complex of therapeutic means [4]. 
The genes of II phase enzyme detoxication of 
the superfamily glutathione S-transferase (GST), 
especially GSTМ1 and GSTТ1 classes, play a key 
role to ensure cellular resistance to lipid peroxide 
oxidation, influence of free radicals on alkylation of 
proteins, prevention of DNA breaking, transport of 
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bilirubin, hormones, and biosynthesis of prostagland-
ins [1, 6], responsibility for the activity of oxidative 
stress in the continuum of cardio-vascular link in 
pathogenesis of diabetic complications [8]. GST-
M1gene deletion is found to be the risk factor for 
coronary artery disease and arterial hypertension, 
and as a result, genotoxic lesion of chromosome by 
the products of thermal decay of tobacco with an 
appropriate expression on the endothelium [5, 9, 10]. 
Although, there are no data concerning the influence 
of mutation genotypes of the above mentioned genes 
of detoxication and antioxidant protection on the 
occurrence of gastroesophageal reflux disease 
(GERD), its complications (erosion, ulcer, bleeding 
etc.) in patients with GERD [5]. 
One more unsolved problem is changes in the 
system of fibrinolysis and proteolysis under condi-
tions of comorbidity of these diseases. Proteolytic 
enzymes and their inhibitors take part in mainte-
nance of the body homeostasis, blood clotting, me-
tabolism, inflammation and digestion. Proteolytic 
activation is treated as the body reaction to lesion 
and results in resistance disorders of the digestive 
mucous membrane. Proteolytic condition depends on 
specific proteins-inhibitors inactivating proteolytic 
enzymes [1, 4, 6]. At the same time, proteolysis is in 
the basis of such vital physiological processes as 
blood clotting, fibrinolysis, regulation of blood pres-
sure etc. Affliction of the epithelial and endothelial 
cells of the digestive tract mucous membrane due to 
increased proteolytic activity of blood plasma is ac-
companied by the activation of coagulation and 
platelet links of hemostasis leading to disorders of 
rheological properties of blood [6]. Therefore, the 
search of previously unknown mechanisms of devel-
opment and progressing of gastroesophageal reflux 
disease (GERD) in patients with IHD and the means 
of effective correction of disorders found is certainly 
topical. 
The question concerning the influence of disor-
ders of psychic status and vegetal dysfunction on 
clinical course and efficacy of treatment of GERD is 
still studied. Certain authors indicate etilogical role 
of stress factors, peculiarities of psychological 
“portrait” of an individual, physical activity and/or 
occupational belonging in the course of the disease. 
One of the mechanisms in the development of motor 
esophageal dysfunction is considered disorders of 
cholinergic innervation of the cardioesophageal zone 
caused by functional imbalance of the parasympa-
thetic and sympathetic links of the autonomous nerv-
ous system (ANS) [8]. Pathological changes in psy-
cho-neurological status due to close relations be-
tween the hypothalamus-pituitary-adrenal system, 
ANS and neuroepithelial cells of APUD-system can 
cause motor-evacuatory dysfunction and develop-
ment of GERD through disorders of topical endo-
crine regulation at the expense of the changes in the 
production of motilin, gastrin, somatostatin, vasoac-
tive intestinal hormone and nitrogen oxide. In these 
conditions specially urgent problem is investigation 
of the role of dysfunction of the central and autono-
mous nervous systems in the initiation of reflux ac-
tivity, clinical course of various variants of GERD 
and their effective correction, as imbalance of these 
two systems provokes the development of disorders 
of the cardio-vascular system function [8]. 
Positive results concerning the influence on the 
vegetal disorders in patients with cardio-vascular 
pathology have demonstrated the use of the medicine 
Noophen (hydrochloride beta-phenyl-gammaamino-
butyric acid). Vegetal-vascular disorders are charac-
terized by a great number of subjective symptoms 
such as emotional disorders, vegetal signs, internal 
tension, anxiety etc. Noophen possesse anti-anxiety, 
nootropic, tranquilizing, vegetostabilizing action, 
improves condition of patients improving their qual-
ity of life [7]. Practical absence of side effects espe-
cially peculiar for muscle relaxants of a central ac-
tion and tranquilizers makes Noophen safe in its use 
in the treatment of vegetal disorders in patients with 
different pathology of the internal organs including 
patients with gastroesophageal reflux disease [7]. 
Conclusion can be drawn that both pathogenic 
mechanisms of development, diagnostic methods and 
strategy of treatment are not studied completely and 
requires urgent correction for successful develop-
ment of internal medicine. 
References 
1. Алексеенко С.А. Алгоритмы диагностики и лечения 
гастроэзофагеальной рефлюксной болезни / С.А. Але-
ксеенко // Фарматека. – 2006. – № 1. – С. 48-49. 
2. Бабак О.Я. Гастроэзофагеальная рефлюксная болезнь / 
О.Я. Бабак, Г.Д. Фадеенко. – К.: Интерфарма, 2000. – 
175 с. 
3. Балаболкин М.И. Дифференциальная диагностика и 
лечение эндокринных заболеваний: Руководство / 
М.И. Балаболкин, Е.М. Клебанова, В.М. Креминская. 
– М.: Медицина, 2002. – 752 с. 
4. Коханюк Ю.В. Спосіб корекції порушень оксидантно-
протиоксидантного гомеостазу у хворих на гастроезо-
фагеальну рефлюксну хворобу у поєднанні з цукро-
вим діабетом типу 2 / Ю.В. Коханюк // Вісн. ВДНЗУ 
«Українська медична стоматологічна академія». – 
2012. – Т. 3 (43), № 13. – С. 159-162. 
5. Коханюк Ю.В. Алелmний стан гена глутатіон s-
трансфераи класу m1 у хворих на гастроеофагеалну 
рефлюксну хворобу і / без цукрового діабету 2-го 
типу / Ю.В. Коханюк // Бук. мед. вісник. – 2013. –  
Т. 17, № 3 (67). – Ч. 2. – С. 31-35. 
6. Коханюк Ю.В. Корекція порушень структурно-
функціонального стану еритроцитів, протеїназо-
інгібіторної системи та фібринолітичної активності 
плазми крові у хворих на гастроезофагеальну рефлюк-
сну хворобу у поєднанні з цукровим діабетом типу 2 / 
Ю.В. Коханюк // Бук. мед. вісник. – 2013. – Т. 17,  
№ 4 (68). – Ч. 2. – С. 31-35. 
7. Кузьминова Н.В. Вегетативные расстройства у пациен-
тов с гипертонической болезнью: диагностика и медика-
ментозная коррекция (1911) / Н.В. Кузьминова, В. К.Сер-
кова // Укр. терапевт. ж. – 2009. – № 2 (70). – C. 37-39. 
8. Осьодло Г.В. Роль вегетативної дисфункції та її корек-
ції при гастроезофагеальній рефлюксній хворобі /  
Г.В. Осьодло, М.В. Радушинська // Гастроентерологія. 
– 2014. – № 2 (52). – С. 13-16. 
9. Трофимов В.И. Глюкокортикоидная функция надпочечни-
ков и уровень мелатонина у больных с аспириновой аст-
мой / В.И. Трофимов, Е.В. Евсюкова, В.Л. Бондаренко // 
Пульмонология. – 1998. – № 2. – С. 68-70. 
 193 
Буковинський медичний вісник        Том 20, № 2 (78), 2016 
 
Рецензент – проф. Т.О. Ілащук                                       Buk. Med. Herald. – 2016. – Vol. 20, № 2 (78). – P. 191-193 
Надійшла до редакції 24.12.2015 року 
 © V.Y.
 Drozd, O.S. Khukhlina, O.E. Mandryk, О.Е. Hryniuk, 2016 
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В.Ю. Дрозд, О.С. Хухлина, О.Е. Мандрик, О.Е. Гриник 
Резюме. В статье освещаются корреляционные связи механизмов развития и прогрессирования гастроэзофаге-
альной рефлюксной болезни у больных хроническими формами ишемической болезни сердца. Описывается про-
блематика лечения в условиях коморбидности этих болезней. 
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